Serum bilirubin concentrations are positively associated with serum C-peptide levels in patients with Type 2 diabetes

Diabet Med. 2014 Nov;31(11):1316-22. doi: 10.1111/dme.12516. Epub 2014 Jun 28.

Abstract

Aims: To investigate the relationship between physiological serum total bilirubin concentrations and serum C-peptide levels in Korean patients with Type 2 diabetes.

Methods: A total of 588 patients with Type 2 diabetes were investigated in this cross-sectional study. Fasting C-peptide level, 2-h postprandial C-peptide level and ΔC-peptide (postprandial C-peptide minus fasting C-peptide) level were measured in all patients.

Results: Fasting C-peptide level, postprandial C-peptide level and ΔC-peptide level tended to be higher in patients with higher bilirubin concentrations. Partial correlation analysis showed that serum bilirubin levels were significantly correlated with fasting C-peptide level (r = 0.159, P < 0.001), postprandial C-peptide level (r = 0.209, P < 0.001) and ΔC-peptide level (r = 0.186, P < 0.001) after adjustment for other covariates. In the multivariate model, the association between serum bilirubin concentrations and serum C-peptide levels remained significant after adjustment for confounding factors including age, gender, familial diabetes, hypertension, hyperlipidaemia, BMI, HbA1c , duration of diabetes and associated liver function tests (fasting C-peptide level: β = 0.083, P = 0.041; postprandial C-peptide level: β = 0.106, P = 0.005; ΔC-peptide level: β = 0.096, P = 0.015, respectively).

Conclusions: Serum bilirubin concentrations within the physiological range were positively associated with serum C-peptide levels in patients with Type 2 diabetes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Bilirubin / blood*
  • Biomarkers / blood
  • C-Peptide / blood*
  • Cross-Sectional Studies
  • Diabetes Mellitus, Type 2 / blood*
  • Diabetes Mellitus, Type 2 / drug therapy
  • Diabetes Mellitus, Type 2 / metabolism
  • Diabetes Mellitus, Type 2 / physiopathology
  • Disease Progression
  • Fasting
  • Female
  • Hospitals, University
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Insulin / metabolism*
  • Insulin Secretion
  • Insulin-Secreting Cells / drug effects
  • Insulin-Secreting Cells / metabolism*
  • Linear Models
  • Male
  • Middle Aged
  • Outpatient Clinics, Hospital
  • Oxidative Stress* / drug effects
  • Postprandial Period
  • Republic of Korea

Substances

  • Biomarkers
  • C-Peptide
  • Hypoglycemic Agents
  • Insulin
  • Bilirubin